Regional methylome profiling reveals dynamic epigenetic heterogeneity and convergent hypomethylation of stem cell quiescence-associated genes in breast cancer following neoadjuvant chemotherapy-Reference-Cited by-全球学者库

Regional methylome profiling reveals dynamic epigenetic heterogeneity and convergent hypomethylation of stem cell quiescence-associated genes in breast cancer following neoadjuvant chemotherapy

Published:2019-02-07 Issue:1 Volume:9 Page:
ISSN:2045-3701
Container-title:Cell & Bioscience
language:en
Short-container-title:Cell Biosci

Author:

Luo Yumei,Huang Juan,Tang Yi,Luo Xitu,Ge Lingxia,Sheng Xiujie,Sun Xiaofang,Chen Yaoyong,Zhu Detu

Funder

Guangzhou Science, Technology and Innovation Commission

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13578-019-0278-y.pdf

Reference42 articles.

1. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet. 2012;13:679–92. https://doi.org/10.1038/nrg3270 .

2. Fong PC, Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A’Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol. 2010;28:2512–9. https://doi.org/10.1200/JCO.2009.26.9589 .

3. Dejeux E, Ronneberg JA, Solvang H, Bukholm I, Geisler S, Aas T, Gut IG, Borresen-Dale AL, Lonning PE, Kristensen VN, Tost J. DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response. Mol Cancer. 2010;9:68. https://doi.org/10.1186/1476-4598-9-68 .

4. Chekhun VF, Kulik GI, Yurchenko OV, Tryndyak VP, Todor IN, Luniv LS, Tregubova NA, Pryzimirska TV, Montgomery B, Rusetskaya NV, Pogribny IP. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett. 2006;231:87–93. https://doi.org/10.1016/j.canlet.2005.01.038 .

5. Ai L, Kim WJ, Demircan B, Dyer LM, Bray KJ, Skehan RR, Massoll NA, Brown KD. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer. Carcinogenesis. 2008;29:510–8. https://doi.org/10.1093/carcin/bgm280 .

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competing endogenous RNA network analysis of Turner syndrome patient-specific iPSC-derived cardiomyocytes reveals dysregulation of autosomal heart development genes by altered dosages of X-inactivation escaping non-coding RNAs;Stem Cell Research & Therapy;2023-12-20

2. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA;International Journal of Molecular Sciences;2023-11-02

3. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets;MedComm;2023-01-16

4. Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer;Cancers;2022-12-23

5. Editorial: Gene regulation mediated by competing RNA: From benchside to bedside;Frontiers in Genetics;2022-11-23